Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Endo, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per | Maximum Aggregate Offering Price(3) | Fee Rate | Amount of Registration Fee | |||||||||
Fees to Be Paid | Equity | Common stock, $0.001 par value per share | Rule 457(c) and Rule 457(h) | 3,600,000(2) | $29.50 | $106,200,000 | 0.00014760 | $15,675.12 | ||||||||
Total Offering Amounts | $106,200,000 | $15,675.12 | ||||||||||||||
Total Fees Previously Paid | ||||||||||||||||
Total Fee Offsets | ||||||||||||||||
Net Fee Due | $15,675.12 |
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 (this “Registration Statement”) also covers additional shares that may become issuable under the Endo, Inc. 2024 Stock Incentive Plan (the “Plan”) by reason of certain corporate transactions or events, including any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of Endo, Inc. (the “Registrant”) outstanding shares of common stock, par value $0.001 per share. |
(2) | Represents 3,600,000 shares of common stock reserved for issuance under the Plan. |
(3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h) of the Securities Act, based on the average of the high and low reported trading prices of the Registrant’s common stock as reported by the OTCQX® Best Market by OTC Markets Group Inc. on July 26, 2024 (a date within five business days prior to the filing of this Registration Statement). |